Lewis T Williams insider trades

Open-market stock purchases and sales by Lewis T Williams, Director at Protagonist Therapeutics, Inc, from SEC Form 4 filings since Jan 7, 2010.

Recent trades

DateStockTradeValue
Feb 17, 2026PTGX Protagonist Therapeutics, IncSold$1.5M
Feb 17, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 2, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—
Jan 2, 2026PTGX Protagonist Therapeutics, IncBought (not open market)—

Companies traded

  • PTGX Protagonist Therapeutics, Inc: 1 sale, last Feb 17, 2026
  • ACLX Arcellx, Inc: other filings, last Feb 8, 2022
  • NLTX Neoleukin Therapeutics, Inc: other filings, last May 11, 2021
  • FPRX Five Prime Therapeutics, Inc: 31 sales, last Sep 1, 2019
  • BEC Beckman Coulter Inc: other filings, last Jun 30, 2011

Get free alerts when Lewis T Williams files a new trade →